The new TNM classification and micrometastases

Area of Science:

• Oncology
• Pathology
• Cancer Staging

Background:

• The TNM classification is crucial for cancer staging and treatment guidance.
• Accurate lymph node analysis is vital for prognosis in various cancers, particularly breast cancer.

Purpose of the Study:

• To critically evaluate the evidence base for lymph node analysis in the 6th Edition TNM classification.
• To assess the implications of micrometastasis definitions and node examination protocols.
• To explore how TNM classification aligns with advances in breast cancer biology.

Main Methods:

• Review of the 6th Edition TNM classification guidelines.
• Analysis of the evidence supporting micrometastasis definitions.
• Consideration of current practices in lymph node examination.
• Discussion of emerging concepts in breast cancer biology.

Main Results:

• The 6th Edition TNM classification's lymph node analysis has limitations due to insufficient evidence for certain definitions, like micrometastasis (<200 microm).
• Lack of standardized node examination protocols hinders inter-center and intra-center data comparability.
• The current TNM framework does not fully incorporate recent advancements in breast cancer biology.

Conclusions:

• While pragmatic, some TNM definitions are based on limited data, affecting its uniformity and evidence-based application.
• Standardized lymph node examination protocols are needed to improve the reliability of TNM staging.
• Future TNM revisions should integrate contemporary breast cancer biology for more accurate staging and treatment decisions.